4//SEC Filing
KAYSEN DAVID B 4
Accession 0001209191-10-033660
CIK 0000890846other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 5:32 PM ET
Size
12.3 KB
Accession
0001209191-10-033660
Insider Transaction Report
Form 4
KAYSEN DAVID B
President, CEO
Transactions
- Award
common stock
2010-06-08+20,300→ 43,550 total - Award
employee non-qualified stock options
2010-06-08+26,075→ 26,075 totalExercise: $4.94From: 2011-06-08Exp: 2017-06-07→ Common Stock (26,075 underlying)
Holdings
- 50,000
employee non-qualified stock options
Exercise: $3.15From: 2008-06-24Exp: 2013-06-23→ Common Stock (50,000 underlying) - 300,000
employee non-qualified stock options
Exercise: $2.50From: 2006-05-17Exp: 2016-05-16→ Common Stock (300,000 underlying) - 50,000
employee non-qualified stock options
Exercise: $4.31From: 2007-07-03Exp: 2012-07-02→ Common Stock (50,000 underlying) - 100,000
employee non-qualified stock options
Exercise: $0.85From: 2009-06-05Exp: 2014-06-04→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Includes 20,300 shares of restricted stock subject to risk of forfeiture that lapses with respect to one fourth of such shares on each of the first, second, third and fourth anniversaries of the grant date (June 8, 2010).
- [F2]Becomes exercisable with respect to one-third of the shares on such date, and an additional, cumulative one-third on the first and second anniversary of such date.
Documents
Issuer
UROPLASTY INC
CIK 0000890846
Entity typeother
Related Parties
1- filerCIK 0001133026
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 5:32 PM ET
- Size
- 12.3 KB